Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alto Neuroscience (ANRO) Gains from Investment Securities (2023 - 2026)

Alto Neuroscience has reported Gains from Investment Securities over the past 4 years, most recently at $190000.0 for Q1 2026.

  • Quarterly results put Gains from Investment Securities at $190000.0 for Q1 2026, up 563.41% from a year ago — trailing twelve months through Mar 2026 was $231000.0 (up 104.33% YoY), and the annual figure for FY2024 was -$52000.0, changed.
  • Gains from Investment Securities reached $190000.0 in Q1 2026 per ANRO's latest filing, up from $156000.0 in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $243000.0 in Q1 2024 and bottomed at -$5.3 million in Q4 2024.
  • Median Gains from Investment Securities over the past 4 years was -$26000.0 (2023), compared with a mean of -$522400.0.
  • The largest annual shift saw Gains from Investment Securities skyrocketed 2309.09% in 2024 before it plummeted 116.87% in 2025.
  • Over 4 years, Gains from Investment Securities stood at -$226000.0 in 2023, then crashed by 2244.25% to -$5.3 million in 2024, then soared by 102.94% to $156000.0 in 2025, then rose by 21.79% to $190000.0 in 2026.
  • Business Quant data shows Gains from Investment Securities for ANRO at $190000.0 in Q1 2026, $156000.0 in Q4 2025, and -$114000.0 in Q3 2025.